Albert Hofmann

Albert Hofmann was a Swiss chemist at Sandoz whose laboratory work gave rise to LSD and later included the isolation of psilocybin and psilocin. His importance lies in the unusual passage of a compound from medicinal research to unexpected psychoactive discovery, then into psychiatric use and wider circulation. In this account, that passage is not presented as a single planned breakthrough: it begins with a search for a drug to stimulate circulation, turns on an accidental ingestion, and ends with LSD’s withdrawal from circulation after it appeared on the black market.

Identity and Laboratory Work

In 1938, Hofmann synthesized LSD while searching for a drug that might stimulate circulation. The compound was the twenty-fifth molecule he had derived from alkaloids produced by ergot, a fungus that infects grain. This origin places LSD within a sustained chemical investigation rather than a deliberate search for a psychoactive substance. At first, the molecule appeared to have no medicinal value for the purpose Hofmann had in mind, and he shelved it.

The early failure matters to the sequence of his work: LSD did not move directly from synthesis into use. It remained an inactive prospect in the laboratory until Hofmann returned to it five years later. The distance between those two stages—making the molecule and recognizing its effects—gives his discovery its contingent character. The compound was already present; what changed was Hofmann’s encounter with it.

The Discovery of LSD’s Effects

Five years after shelving LSD, Hofmann resynthesized it after what the account describes as a premonition. He then accidentally ingested a small quantity. That unplanned exposure revealed the compound’s powerful psychoactive properties and transformed the significance of the earlier laboratory result. A substance first pursued as a possible aid to circulation had become a subject of interest for its effects on consciousness.

The discovery therefore depended on two distinct acts: Hofmann’s decision to make the compound again and the accidental ingestion through which its effects became apparent. The account does not describe the episode as the intended outcome of a controlled medical test. Instead, the turn from chemical synthesis to personal discovery establishes a recurring tension in LSD’s history: scientific investigation could identify a substance, but its uses and meanings extended beyond the purpose for which it had first been made.

Delysid and LSD’s Circulation

In 1947, Sandoz began marketing LSD as a psychiatric drug under the name Delysid. This gave the compound a formal medical identity and placed it in circulation as a potential instrument of psychiatric work. The name Delysid marks a different phase from Hofmann’s initial synthesis: LSD was no longer only a molecule produced in the laboratory, but a drug distributed under a commercial name for psychiatric use.

That medical circulation did not define LSD’s later fate. The compound appeared on the black market, and Sandoz withdrew it from circulation in 1966. The change from psychiatric drug to substance associated with unauthorized public circulation was consequential: the same compound moved between research and wider use, while the institutional setting around it changed. Hofmann’s work is central to this history, but the account distinguishes his discovery from the later events surrounding the drug’s distribution and withdrawal.

Psilocybin and Later Recognition

Hofmann’s chemical work also extended to the isolation of psilocybin and psilocin. This connection places him not only at the beginning of LSD’s history but also in the scientific identification of compounds associated with psychedelic mushrooms. The two strands of work—LSD’s synthesis and the isolation of mushroom compounds—show the breadth of his role in the chemical study of psychedelic substances without collapsing their distinct origins or histories.

A celebration and symposium marked Hofmann’s 100th birthday. The record identifies the commemoration but does not specify its proceedings or arguments. Its inclusion nevertheless places his work within a history that continued to be revisited long after LSD’s withdrawal from circulation. Hofmann’s lasting significance in this account rests on the linked sequence of laboratory inquiry, accidental discovery, psychiatric distribution, and later scientific recognition—not on a claim that one discovery settled what psychedelic compounds were for.